Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Regulatory News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Scientific Director to present at FIDHC

11 Oct 2022 07:00

RNS Number : 3983C
Omega Diagnostics Group PLC
11 October 2022
 

REACH

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

 

Scientific Director to present at FIDHC

Middle East event brings together industry experts and key speakers who are specialists in Gut health

 

Omega (AIM: ODX), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that Dr. Nigel Abraham, Scientific Director at Omega Diagnostics, will be presenting at the International Symposium on Food Intolerance and Digestive Health (FIDHC) in Dubai, taking place on Monday 17 October 2022.

 

Dr. Nigel Abraham, PhD, FIBMS, FRSM, is a specialist in the development, implementation, automation and validation of innovative diagnostic assays and their applications, specialising in the fields of Immunology and allergy. The presentation is entitled: "The Role of Food Sensitivity in Chronic Inflammatory Conditions".

 

FIDHC, organised by Omega's partners in the Middle East, Babirus, is an annual symposium which brings together key speakers who are experts in Gut health. The event offers a platform to educate healthcare professionals in the region about the scientific basis and clinical utility for the use of food IgG antibody testing (food sensitivity) in clinical practice.

 

The symposium attracts more than 500 medical professionals across a number of specialties, including gastroenterologists, dermatologists, pediatricians, GP's, Nutritionists, Dieticians, as well as Pathology. Delegates attending come from government health ministries, public and private hospitals, as well as primary care clinics and include many health professionals who trust Omega's food sensitivity tests and use them in their clinical practice.

 

Jag Grewal, CEO of Omega Diagnostics said: "We are thrilled to be in attendance and presenting at this prestigious symposium, attracting more than 500 medical professionals. We believe that personalised nutrition should sit at the heart of global healthcare and this event allows Omega and our Scientific Director, Dr Nigel Abraham, a platform to educate healthcare professionals in the region about the scientific basis and clinical utility for the use of food IgG antibody testing (food sensitivity) in clinical practice."

 

 

Contacts: 

 

Omega Diagnostics Group PLC

www.omegadx.com

Jag Grewal, Chief Executive Officer

via Walbrook PR

Chris Lea, Chief Financial Officer

finnCap Ltd

Tel: 020 7220 0500

Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance)

Alice Lane/Charlotte Sutcliffe (ECM)

Walbrook PR Limited

Tel: 020 7933 8780 or omega@walbrookpr.com

Paul McManus / Sam Allen / Lianne Applegarth

Mob: 07980 541 893 / 07502 558 258 / 07584 391 303

 

About Omega Diagnostics Group PLC

Omega (AIM: ODX) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.

www.omegadx.com

 

 

 

About Dr. Nigel Abraham, PhD, FIBMS, FRSM

Nigel is Scientific Director at Omega Diagnostics Ltd., UK, and a specialist in the development, implementation, automation and validation of innovative diagnostic assays and their applications.

 

Specialising in the fields of Immunology and allergy, Nigel was trained originally in pathology at St. Georges Medical School and went on to study Immunology at the University of Surrey. A specialist in allergy and hormones he has been involved in extensive research in the field of chemical mediators of allergic disease and salivary hormone diagnostics. He is a Fellow of the Institute of Biomedical Science and a chartered scientist, formerly the Scientific Director of Genova Diagnostics (Europe), and leading a specialist laboratory team performing a comprehensive range of tests in functional and nutritional medicine. He is also a keen participant in both student and practitioner education lecturing at many of the major education centre's as well as regularly holding seminars and presentations as part of the continuing professional development for practitioners. Nigel has been involved in many research projects and have published a number of scientific papers.

 

About FIDHC

https://www.fidhc.com/

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAKEEFDSAFFA
Date   Source Headline
22nd May 202012:30 pmRNSExercise of Options and TVR
15th May 202011:05 amRNSSecond Price Monitoring Extn
15th May 202011:00 amRNSPrice Monitoring Extension
13th May 20202:00 pmRNSPrice Monitoring Extension
7th May 20208:15 amRNSExercise of Options and TVR
6th May 202011:00 amRNSPrice Monitoring Extension
4th May 202011:00 amRNSExercise of Options and TVR
1st May 20202:30 pmRNSHolding(s) in Company
1st May 20202:05 pmRNSSecond Price Monitoring Extn
1st May 20202:00 pmRNSPrice Monitoring Extension
30th Apr 202012:00 pmRNSExercise of Options and TVR
29th Apr 20205:37 pmRNSHolding(s) in Company
29th Apr 20207:00 amRNSHolding(s) in Company
28th Apr 20205:43 pmRNSHolding(s) in Company
28th Apr 20207:00 amRNSVISITECT® CD4 Advanced Disease - supply agreement
27th Apr 20204:42 pmRNSSecond Price Monitoring Extn
27th Apr 20204:36 pmRNSPrice Monitoring Extension
27th Apr 20209:06 amRNSSecond Price Monitoring Extn
27th Apr 20209:00 amRNSPrice Monitoring Extension
27th Apr 20207:00 amRNSCE-Mark of COVID-19 ELISA antibody test
24th Apr 202011:00 amRNSPrice Monitoring Extension
20th Apr 20202:05 pmRNSSecond Price Monitoring Extn
20th Apr 20202:00 pmRNSPrice Monitoring Extension
20th Apr 20201:24 pmRNSHolding(s) in Company
20th Apr 20201:23 pmRNSHolding(s) in Company
20th Apr 20207:00 amRNSHolding(s) in Company
20th Apr 20207:00 amRNSCOVID-19 MTA signed with Mologic Ltd
16th Apr 20205:40 pmRNSHolding(s) in Company
16th Apr 20207:00 amRNSHolding(s) in Company
14th Apr 20203:06 pmRNSHolding(s) in Company
9th Apr 20204:41 pmRNSSecond Price Monitoring Extn
9th Apr 20204:36 pmRNSPrice Monitoring Extension
9th Apr 20207:00 amRNSCOVID-19 Consortium MOU
6th Apr 20209:30 amRNSVISITECT® CD4 Advanced Disease evaluation
6th Apr 20208:34 amRNSHolding(s) in Company
2nd Apr 20207:00 amRNSChinese Approval for Food Detective® test
2nd Apr 20207:00 amRNSTrading Update
24th Jan 20207:00 amRNSGrant of Options under Company EMI Plan
21st Jan 20203:24 pmRNSHolding(s) in Company
20th Jan 20207:00 amRNSExercise of Options and Total Voting Rights
17th Jan 202010:30 amRNSNigerian MOH approval for VISITECT CD4 350 test
8th Jan 202012:13 pmRNSHolding(s) in Company
16th Dec 20194:05 pmRNSDirector/PDMR Shareholding
9th Dec 20194:30 pmRNSHolding(s) in Company
2nd Dec 20199:00 amRNSGrant of Share Options
2nd Dec 20197:00 amRNSInterim Results
2nd Dec 20197:00 amRNSNigerian order for VISITECT® CD4
25th Nov 20197:00 amRNSUpdate on Allergy test menu
21st Nov 20197:00 amRNSInvestor results briefing
22nd Oct 201911:39 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.